Press Release

Questioning The Rebate Rule

Mar 12, 2019

Secretary Azar Recently Noted The Effectiveness Of PBMs Now Targeted By Agency Read More

Trump Administration Should Focus on Market-Based Solutions to Alleviate Drug Prices

Mar 11, 2019

As Secretary Azar Heads To Capitol Hill, CSRxP Encourages Lawmakers To Read More

Skyrocketing Drug Prices Place Extreme Financial Burdens On Families

Mar 7, 2019

Patients Tell Congress, Paying For Life-Saving Medications Often Means Going Read More

CSRxP Praises Gottlieb For Leadership On Drug Pricing

Mar 6, 2019

FDA Commissioner Was Invaluable Voice In Favor Of Market-Based Solutions To Read More

Pace Of Drug Price Activity In Congress A Reason For Optimism

Mar 5, 2019

Three More Hearings Will Keep Attention On The Impact Of Big Pharma’s Read More

CSRxP Statement on Testimony of Seven Pharmaceutical Executives Before Senate Finance Committee

Feb 26, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released Read More

Congress Answering Americans’ Call To Action On Drug Pricing

Feb 11, 2019

The momentum in Congress to act on out-of-control drug prices will continue to Read More

Family outraged over life-changing treatment going from free to $375,000 a year

Feb 7, 2019

NBC News Ben Kesslen February 7, 2019 “I don’t think I would be alive Read More

Momentum Builds for Bipartisan CREATES Act

Feb 7, 2019

For Immediate Release Contact: Lauren Blair 201-213-5004 lblair@fp1strategies. Read More

CSRxP Statement On State Of The Union Address

Feb 6, 2019

For Immediate Release Contact: Lauren Blair 201-213-5004 [email protected] Read More

SOTU: It’s Time To Come Together To Tackle Drug Prices

Feb 5, 2019

Tonight, Americans from across the country will tune-in to listen to the Read More

CSRxP Leads Diverse Group Of Nearly 50 Organizations In Pledging Support For Bipartisan CREATES Act

Feb 5, 2019

Legislation Would Lower Prescription Drug Prices, Increase Competition, Read More